Anti‐FcεRIα serum autoantibodies in different subtypes of urticaria
- 1 October 2000
- Vol. 55 (10) , 951-954
- https://doi.org/10.1034/j.1398-9995.2000.00445.x
Abstract
Background: In recent years, a histamine‐releasing anti‐FcεRIα autoantibody has been demonstrated in about one‐third of patients with chronic urticaria. However, its clinical significance is still unclear. The objective was to detect a possible correlation between the occurrence of the anti‐FcεRIα autoantibody and the clinical type or cause of urticaria. Methods: Sera from 66 consecutively seen in‐ and outpatients with various types of urticaria and five healthy controls were examined for the presence of anti‐FcεRIα autoantibodies with a sandwich ELISA technique. In addition, basophil histamine release was studied in 13 autoantibody‐positive sera. Results: Anti‐FcεRIα autoantibodies were found in 17/48 patients with chronic urticaria, in 2/4 with angioedema, in 1/2 with urticarial vasculitis, and in 2/11 with dermographic urticaria. However, no anti‐FcεRIα autoantibodies were detected in acute, cold, or delayed‐pressure urticaria; in urticaria pigmentosa; or in normal controls. Of all chronic urticaria patients, 22 were classified as idiopathic since no underlying cause could be found. Of this group, seven were seropositive for anti‐FcεRIα. However, anti‐FcεRIα was also found in patients who went into remission after treatment of identified causes; namely, in one with type I allergy, one with drug intolerance, one with Helicobacter infection, and six with food intolerance. The autoantibody was also detected in 2/4 patients with associated autoimmune diseases. Functional activity was shown in basophil histamine release in 3/4 autoantibody‐positive sera of patients with chronic idiopathic urticaria and in 4/6 autoantibody‐positive sera of patients who went into remission after the treatment of underlying causes. Conclusions: These data confirm that anti‐FcεRIα autoantibodies in urticaria are mostly found in chronic urticaria. Furthermore, their detection independently of the apparent cause of the urticaria suggests that as yet unidentified mechanisms must be operative, possibly related to the chronic inflammatory process and/or individual predispositions that favor their induction.Keywords
This publication has 23 references indexed in Scilit:
- Human anti-FcεRIα autoantibodies isolated from healthy donors cross-react with tetanus toxoidEuropean Journal of Immunology, 1999
- Cutaneous inflammatory cell infiltrate in chronic idiopathic urticaria: Comparison of patients with and without anti-FcϵRI or anti-IgE autoantibodiesPublished by Elsevier ,1999
- Chronic idiopathic urticaria: Comparison of the clinical features of patients with and without anti-FcϵRI or anti-IgE autoantibodiesJournal of the American Academy of Dermatology, 1999
- Upregulation of TNF-α and IL-3 expression in lesional and uninvolved skin in different types of urticariaJournal of Allergy and Clinical Immunology, 1999
- Anti-FcepsilonRIalpha autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship.Journal of Clinical Investigation, 1998
- Low‐dose cyclosporin A in the treatment of severe chronic idiopathic urticariaAllergy, 1997
- Anti-IgE and anti-FcεRI autoantibodies in clinical allergyCurrent Opinion in Immunology, 1996
- MHC Class II Antigen Expression Is Increased in Different Forms of UrticariaInternational Archives of Allergy and Immunology, 1996
- Serum IgG autoantibodies directed against the alpha chain of Fc epsilon RI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients?Journal of Clinical Investigation, 1995
- The pathogenesis of chronic idiopathic urticaria: new evidence suggests an auto–immune basis and implications for treatmentClinical and Experimental Allergy, 1994